SNP (rsID),Chr,Position,Genotype,Gene,"Clinical_Effect : L( Least Risk common mutation), M(medium risk), H (highest Risk)",Associated_Conditions for given Genotype and its Risk,Common Variant Name,,,,,,,,,,,,,,
rs10033464,4,111720761,GT,GCKR,M,"Atrial fibrillation(M), cardioembolic stroke(M), hypertriglyceridemia(M)",Triglyceride-associated,,,,,,,,,,,,,,
rs1024611,17,32579788,AA,CCL2,M,"Coronary artery disease(M), inflammation-related disorders(M)",-2518A>G,,,,,,,,,,,,,,
rs1042636,3,122003769,AA,CYP2R1,L,None significant for AA genotype,Vitamin D metabolism,,,,,,,,,,,,,,
rs1042713,5,148206440,GG,ADRB2,M,"Asthma(M), cardiovascular response to beta-agonists(M)",Arg16Gly (G46A),,,,,,,,,,,,,,
rs10455872,6,161010118,AA,LPA,H,"Coronary artery disease(H), myocardial infarction(H)",Lipoprotein(a)-associated,,,,,,,,,,,,,,
rs10490924,10,124214448,GT,ARMS2,H,Age-related macular degeneration(H),A69S (Ala69Ser),,,,,,,,,,,,,,
rs1051266,21,46957794,CC,SLC19A1,L,None significant for CC genotype,Folate metabolism,,,,,,,,,,,,,,
rs10519210,15,63737925,TT,TMEM57,L,None significant for TT genotype,No specific variant name,,,,,,,,,,,,,,
rs1057910,10,96741053,AC,CYP2C9,H,"Warfarin sensitivity(H), bleeding risk(H)",CYP2C9*3 (Ile359Leu),,,,,,,,,,,,,,
rs1061170,1,196659237,CT,CFH,M,"Age-related macular degeneration(M), weak CHD/stroke risk(L)",Y402H (Tyr402His),,,,,,,,,,,,,,
rs10757274,9,22096055,GG,CDKN2B-AS1,M,"Coronary artery disease(M), type 2 diabetes(M)",9p21 cardiovascular risk,,,,,,,,,,,,,,
rs10821415,9,97713459,CC,C9orf72,L,None significant for CC genotype,Neurological risk,,,,,,,,,,,,,,
rs10824026,10,75421208,AA,SYNM,L,None significant for AA genotype,No specific variant name,,,,,,,,,,,,,,
rs11172782,12,59259628,AA,LRRC10B,L,None significant for AA genotype,No specific variant name,,,,,,,,,,,,,,
rs11190870,10,102979207,CT,LBX1,M,Adolescent idiopathic scoliosis(M),Scoliosis-associated,,,,,,,,,,,,,,
rs11209026,1,67705958,GG,IL23R,L,None significant for GG genotype (protective for IBD),R381Q,,,,,,,,,,,,,,
rs1142345,6,18130918,TT,TPMT,H,"Thiopurine toxicity(H), leukemia treatment complications(H)",TPMT*3C (Tyr240Cys),,,,,,,,,,,,,,
rs11549465,14,62207557,CC,HIF1A,L,None significant for CC genotype,P582S (Pro582Ser),,,,,,,,,,,,,,
rs11558471,8,118185733,AA,SLC30A8,M,Type 2 diabetes(M),Diabetes risk,,,,,,,,,,,,,,
rs11591147,1,55505647,GG,PCSK9,L,None significant for GG genotype,R46L (Arg46Leu),,,,,,,,,,,,,,
rs11747270,5,150258867,AG,IRF4,L,None significant for AG genotype,Pigmentation-associated,,,,,,,,,,,,,,
rs12970134,18,57884750,GG,MC4R,M,"Obesity(M), type 2 diabetes(M)",Obesity risk,,,,,,,,,,,,,,
rs12979860,19,39738787,CT,IFNL3,M,"Hepatitis C treatment response(M), chronic hepatitis C(M)",Hepatitis C response,,,,,,,,,,,,,,
rs1333049,9,22125503,CC,CDKN2B-AS1,M,"Coronary artery disease(M), type 2 diabetes(M)",9p21 cardiovascular risk,,,,,,,,,,,,,,
rs13376333,1,154681353,CC,KCNN3,M,Atrial fibrillation(M),Atrial fibrillation risk,,,,,,,,,,,,,,
rs1532268,5,7878179,CT,MTRR,M,"Homocysteine levels(M), neural tube defects(M)",Methionine metabolism,,,,,,,,,,,,,,
rs1544410,12,48237457,TT,VDR,L,None significant for TT genotype,BsmI (G>A),,,,,,,,,,,,,,
rs1570360,6,43770616,AA,VEGFA,M,"Cancer progression(M), diabetic retinopathy(M)",VEGF expression,,,,,,,,,,,,,,
rs162036,5,7887873,AA,MTRR,L,None significant for AA genotype,No specific variant name,,,,,,,,,,,,,,
rs16944,2,112832814,GG,IL1B,M,"Inflammatory disorders(M), gastric cancer risk(M)",-511C>T,,,,,,,,,,,,,,
rs17042171,4,111705768,CC,GCKR,M,"Metabolic syndrome(M), hypertriglyceridemia(M)",Lipid metabolism,,,,,,,,,,,,,,
rs174537,11,61570783,GT,FADS1,M,"Lipid metabolism(M), coronary artery disease(M)",Fatty acid metabolism,,,,,,,,,,,,,,
rs174547,11,61576986,CT,FADS1,M,"Lipid metabolism(M), coronary artery disease(M)",Fatty acid metabolism,,,,,,,,,,,,,,
rs174550,11,61577681,CT,FADS1,M,"Lipid metabolism(M), coronary artery disease(M)",Fatty acid metabolism,,,,,,,,,,,,,,
rs174575,11,61613312,CG,FADS2,M,"Lipid metabolism(M), cognitive development(M)",Fatty acid metabolism,,,,,,,,,,,,,,
rs1799853,10,96578013,CC,CYP2C9,M,Warfarin sensitivity(M),CYP2C9*2 (Arg144Cys),,,,,,,,,,,,,,
rs1799941,17,7633210,GG,CRHBP,L,None significant for GG genotype,No specific variant name,,,,,,,,,,,,,,
rs1799945,6,26037527,CG,HFE,M,Hemochromatosis(M),H63D (His63Asp),,,,,,,,,,,,,,
rs1800012,17,5030995,CC,COL1A1,M,"Osteoporosis(M), fracture risk(M)",Sp1 binding site,,,,,,,,,,,,,,
rs1800469,19,41354390,GG,TGFB1,M,"Fibrosis(M), cancer susceptibility(M)",-509C>T,,,,,,,,,,,,,,
rs1800470,19,41353111,AA,TGFB1,M,"Fibrosis(M), cancer susceptibility(M)",Leu10Pro,,,,,,,,,,,,,,
rs1800544,10,112998810,CG,ADRB2,M,"Asthma(M), cardiovascular response to beta-agonists(M)",Gln27Glu,,,,,,,,,,,,,,
rs1800562,6,26025782,GG,HFE,H,Hemochromatosis(H),C282Y (Cys282Tyr),,,,,,,,,,,,,,
rs1800587,2,112837290,AG,IL1A,M,"Inflammatory disorders(M), rheumatoid arthritis(M)",-889C>T,,,,,,,,,,,,,,
rs1800588,15,58439637,CC,LIPC,M,"Lipid metabolism(M), coronary artery disease(M)",Hepatic lipase promoter,,,,,,,,,,,,,,
rs1800629,6,31575254,GG,TNF,M,"Inflammatory disorders(M), autoimmune diseases(M)",-308G>A,,,,,,,,,,,,,,
rs1800795,7,22732008,GC,IL6,M,"Inflammatory disorders(M), cardiovascular disease(M)",-174G>C,,,,,,,,,,,,,,
rs1800796,7,22732009,AG,IL6,M,"Inflammatory disorders(M), cardiovascular disease(M)",-598G>A,,,,,,,,Associated_Conditions for given Genotype,,,,,,
rs1801131,1,11854476,GT,MTHFR,M,"Homocysteine levels(M), neural tube defects(M)",A1298C,,,,,,,,,,,,,,
rs1801133,1,11856378,GG,MTHFR,M,"Homocysteine levels(M), cardiovascular disease(M)",C677T,,,,,,,,,,,,,,
rs1801253,10,115805056,CG,ADRB1,M,"Hypertension(M), heart failure response to beta-blockers(M)",Gly389Arg,,,,,,,,,,,,,,
rs1801274,1,161479745,AG,FCGR2A,M,"Systemic lupus erythematosus(M), immune response disorders(M)",H131R,,,,,,,,,,,,,,
rs1801280,8,18257854,CT,NAT2,M,"Drug metabolism (isoniazid)(M), bladder cancer risk(M)",NAT2*6A (G590A),,,,,,,,,,,,,,
rs1801282,3,12393125,CC,PPARG,M,"Type 2 diabetes(M), insulin resistance(M)",Pro12Ala,,,,,,,,,,,,,,
rs1801394,5,7870973,AA,MTRR,M,"Homocysteine levels(M), neural tube defects(M)",A66G,,,,,,,,,,,,,,
rs1805087,1,237048500,GG,MTR,M,"Homocysteine levels(M), neural tube defects(M)",A2756G,,,,,,,,,,,,,,
rs1946518,11,112035458,GT,IL18,M,"Inflammatory disorders(M), coronary artery disease(M)",-607C>A,,,,,,,,,,,,,,
rs1979277,17,18232096,AG,SHMT1,L,None significant for AG genotype,L474F,,,,,,,,,,,,,,
rs199984328,2,44047175,GG,MSH2,L,None significant for GG genotype,No specific variant name,,,,,,,,,,,,,,
rs2010963,6,43738350,GG,VEGFA,M,"Cancer progression(M), diabetic retinopathy(M)",-634G>C,,,,,,,,,,,,,,
rs201601231,12,111744875,GG,SH2B3,M,"Coronary artery disease(M), hypertension(M)",No specific variant name,,,,,,,,,,,,,,
rs2066844,16,50745926,CC,NOD2,H,"Crohn’s disease(H), inflammatory bowel disease(H)",R702W,,,,,,,,,,,,,,
rs2106261,16,73051620,CC,ZNF423,L,None significant for CC genotype,No specific variant name,,,,,,,,,,,,,,
rs2187668,6,32605884,CC,HLA-DQA1,H,Celiac disease(H),Celiac disease risk,,,,,,,,,,,,,,
rs2200733,4,111710169,CC,PITX2,M,Atrial fibrillation(M),Atrial fibrillation risk,,,,,,,,,,,,,,
rs2201841,1,67694202,GG,IL23R,L,None significant for GG genotype (protective for IBD),Inflammatory disease risk,,,,,,,,,,,,,,
rs2228084,1,45479709,AA,FCGR3A,L,None significant for AA genotype,No specific variant name,,,,,,,,,,,,,,
rs2228671,19,11210912,--,LDLR,-,None (invalid genotype),No specific variant name,,,,,,,,,,,,,,
rs2230199,19,6718387,GG,C3,M,"Age-related macular degeneration(M), immune-mediated diseases(M)",R102G,,,,,,,,,,,,,,
rs2230926,6,138196066,TT,TNFAIP3,M,"Autoimmune diseases (e.g., rheumatoid arthritis)(M)",No specific variant name,,,,,,,,,,,,,,
rs2232365,X,49115886,T,FOXP3,M,"Autoimmune disorders (e.g., IPEX syndrome in males)(M)",No specific variant name,,,,,,,,,,,,,,
rs2234693,6,152163335,CT,ESR1,M,"Breast cancer risk(M), bone mineral density(M)",PvuII (C>T),,,,,,,,,,,,,,
rs2236225,14,64908845,GG,MTHFD1,M,"Neural tube defects(M), folate metabolism disorders(M)",No specific variant name,,,,,,,,,,,,,,
rs2237892,11,2839751,CC,KCNQ1,M,Type 2 diabetes(M),Diabetes risk,,,,,,,,,,,,,,
rs2241880,2,234183368,AA,ATG16L1,H,"Crohn’s disease(H), inflammatory bowel disease(H)",T300A,,,,,,,,,,,,,,
rs2274976,1,11850927,CC,MTHFR,L,None significant for CC genotype,Ala‑429 variant? less known,,,,,,,,,,,,,,
rs2275565,1,237048676,TT,MTR,L,None significant for TT genotype,No specific variant name,,,,,,,,,,,,,,
rs2275913,6,52051033,GG,IL17A,M,"Autoimmune diseases (e.g., psoriasis)(M)",-197G>A,,,,,,,,,,,,,,
rs2282679,4,72608383,TT,GC,M,"Vitamin D deficiency(M), bone health(M)",Vitamin D binding,,,,,,,,,,,,,,
rs2294008,8,143761931,CT,PSCA,M,"Prostate cancer(M), gastric cancer(M)",Prostate cancer risk,,,,,,,,,,,,,,
rs2306283,12,21329738,AA,SLCO1B1,M,"Statin pharmacokinetics(M), myopathy risk(M)",*1B (Asn130Asp),,,,,,,,,,,,,,
rs234706,21,44485350,GG,CBS,L,None significant for GG genotype,No specific variant name,,,,,,,,,,,,,,
rs234709,21,44486964,CT,CBS,L,None significant for CT genotype,No specific variant name,,,,,,,,,,,,,,
rs2395029,6,31431780,TT,HCP5,M,"Psoriasis(M), HIV progression(M)",Psoriasis risk,,,,,,,,,,,,,,
rs2472300,15,75033909,AA,CYP1A2,L,None significant for AA genotype,No specific variant name,,,,,,,,,,,,,,
rs2542151,18,12779947,TT,PTPN2,M,"Type 1 diabetes(M), Crohn’s disease(M)",Autoimmune disease risk,,,,,,,,,,,,,,
rs2736340,8,11343973,CC,BLK,M,"Systemic lupus erythematosus(M), autoimmune diseases(M)",Autoimmune disease risk,,,,,,,,,,,,,,
rs2814778,1,159174683,TT,ACKR1,M,"Duffy-negative phenotype(M), malaria resistance(M)",Duffy antigen (FY*0),,,,,,,,,,,,,,
rs28399504,10,96522463,AA,CYP2C19,H,"Clopidogrel resistance(H), cardiovascular event risk(H)",CYP2C19*4 (1A>G),,,,,,,,,,,,,,
rs2851391,21,44487404,CT,CBS,L,None significant for CT genotype,No specific variant name,,,,,,,,,,,,,,
rs28929474,14,94844947,CC,SERPINA1,H,"Alpha-1 antitrypsin deficiency(H), liver/lung disease(H)",Z allele (Glu342Lys),,,,,,,,,,,,,,
rs28937592,5,121786403,CC,TSLP,L,None significant for CC genotype,No specific variant name,,,,,,,,,,,,,,
rs3184504,12,111884608,CC,SH2B3,M,"Coronary artery disease(M), hypertension(M)",No specific variant name,,,,,,,,,,,,,,
rs3212227,5,158742950,TT,IL12B,M,"Psoriasis(M), autoimmune diseases(M)",No specific variant name,,,,,,,,,,,,,,
rs3729547,1,201334382,AA,GSTM3,L,None significant for AA genotype,No specific variant name,,,,,,,,,,,,,,
rs3729986,11,47371598,CT,VDR,L,None significant for CT genotype,No specific variant name,,,,,,,,,,,,,,
rs3733890,5,78421959,AG,BHMT,M,"Homocysteine levels(M), cardiovascular disease(M)",R239Q,,,,,,,,,,,,,,
rs3734523,6,25925987,GG,HFE,L,None significant for GG genotype,No specific variant name,,,,,,,,,,,,,,
rs3768142,1,237028564,TT,MTR,L,None significant for TT genotype,No specific variant name,,,,,,,,,,,,,,
rs3798220,6,160961137,TT,LPA,H,"Coronary artery disease(H), atherosclerosis(H)",I4399M,,,,,,,,,,,,,,
rs3807989,7,116186241,GG,CAV1,M,"Coronary artery disease(M), breast cancer risk(M)",No specific variant name,,,,,,,,,,,,,,
rs3808607,8,59412924,GT,CYP7A1,M,"Hypercholesterolemia(M), gallstone disease(M)",-204A>C,,,,,,,,,,,,,,
rs3918290,1,97915614,CC,DPYD,H,"Fluoropyrimidine toxicity(H), chemotherapy complications(H)",DPYD*2A (IVS14+1G>A),,,,,,,,,,,,,,
rs41272114,6,161006077,CC,LPA,L,None significant for CC genotype,No specific variant name,,,,,,,,,,,,,,
rs4148323,2,234669144,GG,UGT1A1,H,"Irinotecan toxicity(H), Gilbert syndrome(M)",UGT1A1*6 (G71R),,,,,,,,,,,,,,
rs4149056,12,21331549,TT,SLCO1B1,H,"Statin-induced myopathy(M), lipid metabolism(M)",*5 (Val174Ala),,,,,,,,,,,,,,
rs4244285,10,96541616,GG,CYP2C19,H,Clopidogrel metabolism(M),CYP2C19*2 (681G>A),,,,,,,,,,,,,,
rs429358,19,45411941,CT,APOE,H,"Alzheimer’s disease(H), cardiovascular disease(H)",ε4 (Cys112Arg),,,,,,,,,,,,,,
rs4343,17,61566031,AG,ACE,M,"Hypertension(M), cardiovascular disease(M)",I/D polymorphism,,,,,,,,,,,,,,
rs4633,22,19950235,CT,COMT,L,Psychiatric disorders(M),His62His,,,,,,,,,,,,,,
rs4646,15,51502844,CC,CYP19A1,L,None significant for CC genotype,No specific variant name,,,,,,,,,,,,,,
rs4680,22,19951271,AG,COMT,M,"Psychiatric disorders(M), pain sensitivity(M)",Val158Met,,,,,,,,,,,,,,
rs4870044,6,151901409,CC,ESR1,L,None significant for CC genotype,No specific variant name,,,,,,,,,,,,,,
rs4880,6,160113872,GG,SOD2,M,"Oxidative stress-related disorders(M), cancer risk(M)",Ala16Val,,,,,,,,,,,,,,
rs4920037,21,44481891,GG,CBS,L,None significant for GG genotype,No specific variant name,,,,,,,,,,,,,,
rs492602,19,49206417,AA,FUT2,M,"Gut microbiome alterations(M), vitamin B12 deficiency(M)",W143X,,,,,,,,,,,,,,
rs4988235,2,136608646,GG,MCM6,M,Lactose intolerance(M),-13910C>T (Lactase persistence),,,,,,,,,,,,,,
rs5082,1,161193683,AA,APOA2,M,"Obesity(M), lipid metabolism disorders(M)",-265T>C,,,,,,,,,,,,,,
rs5128,11,116703640,CG,APOC3,M,"Hypertriglyceridemia(M), coronary artery disease(M)",3'UTR variant,,,,,,,,,,,,,,
rs562556,1,55524237,AA,PCSK9,L,None significant for AA genotype,No specific variant name,,,,,,,,,,,,,,
rs5742904,2,21229160,CC,CTLA4,M,"Autoimmune diseases (e.g., type 1 diabetes)(M)",Thr17Ala,,,,,,,,,,,,,,
rs58542926,19,19379549,CC,TM6SF2,H,"Non-alcoholic fatty liver disease(H), liver fibrosis(H)",E167K,,,,,,,,,,,,,,
rs5945619,X,51241672,T,NUDT15,M,"Thiopurine toxicity(M), leukemia treatment complications(M)",No specific variant name,,,,,,,,,,,,,,
rs6025,1,169519049,CC,F5,H,"Thrombophilia(H), venous thromboembolism(H)",Leiden (Arg506Gln),,,,,,,,,,,,,,
rs6277,11,113283459,AG,DRD2,M,"Addiction(M), psychiatric disorders(M)",957C>T,,,,,,,,,,,,,,
rs6441961,3,46352384,CT,CCR5,M,"HIV resistance(M), inflammatory disorders(M)",No specific variant name,,,,,,,,,,,,,,
rs646776,1,109818530,TT,CELSR2,M,"Coronary artery disease(M), lipid metabolism(M)",Lipid metabolism,,,,,,,,,,,,,,
rs662,7,94937446,CC,PON1,M,"Coronary artery disease(M), oxidative stress(M)",Q192R,,,,,,,,,,,,,,
rs6666258,1,154814268,GG,KCNN3,L,None significant for GG genotype,No specific variant name,,,,,,,,,,,,,,
rs670,11,116708413,CC,APOA4,L,None significant for CC genotype,No specific variant name,,,,,,,,,,,,,,
rs671,12,112241766,GG,ALDH2,H,"Alcohol intolerance(H), esophageal cancer risk(H)",Glu504Lys,,,,,,,,,,,,,,
rs6738825,2,198896895,AG,PLCL1,L,None significant for AG genotype,No specific variant name,,,,,,,,,,,,,,
rs6817105,4,111705768,TT,PITX2,M,Atrial fibrillation(M),Atrial fibrillation risk,,,,,,,,,,,,,,
rs688,19,11227602,CC,LDLR,L,None significant for CC genotype,No specific variant name,,,,,,,,,,,,,,
rs699,1,230845794,AG,AGT,M,"Hypertension(M), cardiovascular disease(M)",M235T (Met235Thr),,,,,,,,,,,,,,
rs700518,15,51529112,CT,CYP19A1,L,None significant for CT genotype,No specific variant name,,,,,,,,,,,,,,
rs708272,16,56996288,AG,CETP,M,"Coronary artery disease(M), HDL cholesterol levels(M)",TaqIB (G>A),,,,,,,,,,,,,,
rs731236,12,48238757,GG,VDR,L,None significant for GG genotype,TaqI (T>C),,,,,,,,,,,,,,
rs738409,22,44324727,CC,PNPLA3,H,"Non-alcoholic fatty liver disease(H), liver fibrosis(H)",I148M,,,,,,,,,,,,,,
rs7412,19,45412079,CC,APOE,M,"Cardiovascular disease(M), dyslipidemia(M)",ε2 (Arg158Cys),,,,,,,,,,,,,,
rs7454108,6,32681483,TT,HLA-DQB1,H,Celiac disease(H),Celiac disease risk,,,,,,,,,,,,,,
rs749292,15,51558731,AG,CYP19A1,L,None significant for AG genotype,No specific variant name,,,,,,,,,,,,,,
rs763780,6,52101739,TT,IL17F,M,"Autoimmune diseases (e.g., ulcerative colitis)(M)",His161Arg,,,,,,,,,,,,,,
rs776746,7,99270539,CC,CYP3A5,H,"Tacrolimus metabolism(H), transplant complications(H)",CYP3A5*3 (6986A>G),,,,,,,,,,,,,,
rs7903146,10,114758349,CT,TCF7L2,M,Type 2 diabetes(M),Diabetes risk,,,,,,,,,,,,,,
rs7946,17,17409560,CT,PEMT,M,"Non-alcoholic fatty liver disease(M), choline metabolism(M)",Val175Met,,,,,,,,,,,,,,
rs7975232,12,48238837,AA,VDR,L,None significant for AA genotype,ApaI (G>T),,,,,,,,,,,,,,
rs800292,1,196642233,GG,CFH,M,"Age-related macular degeneration(M), weak CHD/stroke risk(L)",I62V (Ile62Val),,,,,,,,,,,,,,
rs8192678,4,23815662,CC,PPARGC1A,M,"Type 2 diabetes(M), metabolic syndrome(M)",Gly482Ser,,,,,,,,,,,,,,
rs9264942,6,31274380,CT,HLA-C,M,"Psoriasis(M), HIV control(M)",-35C>T,,,,,,,,,,,,,,
rs951005,9,34743681,GG,C5,L,None significant for GG genotype,No specific variant name,,,,,,,,,,,,,,
rs9885413,5,110176128,GG,SLC22A5,L,None significant for GG genotype,No specific variant name,,,,,,,,,,,,,,
rs9923231,16,31107689,CC,VKORC1,H,"Warfarin sensitivity(H), bleeding risk(H)",-1639G>A,,,,,,,,,,,,,,
rs16147,7,24323410,TT,NPY,M,"Tobacco smoking(M), state anxiety(M)",,,,,,,,,,,,,,,
rs6190,5,142780337,CC,NR3C1,L,"Glucocorticoid sensitivity(L), stress-related disorders(L)",,,,,,,,,,,,,,,
rs4964181,12,106989625,CC,Unknown,L,None significant for CC genotype,,,,,,,,,,,,,,,
rs10757278,9,22124477,GG,CDKN2B-AS1,M,"Coronary artery disease(M), type 2 diabetes(M)",,,,,,,,,,,,,,,
rs2383207,9,22115959,GG,CDKN2B-AS1,M,"Coronary artery disease(M), stroke(M)",,,,,,,,,,,,,,,
rs17672135,1,240445596,TT,FMN2,L,None significant for TT genotype,,,,,,,,,,,,,,,
rs8055236,16,83212398,GG,CDH13,M,"Coronary artery disease(M), psychiatric disorders(M)",,,,,,,,,,,,,,,
rs599839,1,109822166,AA,CELSR2,M,"Coronary artery disease(M), lipid metabolism(M)",,,,,,,,,,,,,,,
rs17465637,1,222823529,CC,MIA3,M,Coronary artery disease(M),,,,,,,,,,,,,,,
rs11556924,7,129663496,CC,ZC3HC1,M,Coronary artery disease(M),,,,,,,,,,,,,,,
rs4665058,2,160190209,CC,Intergenic,M,Coronary artery disease(M),,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,
